Jingze Biopharmaceutical (Hefei) Co., Ltd

景泽生物医药(合肥)股份有限公司

Biopharmaceutical company in China developing and manufacturing assisted reproductive drugs (rhFSH injections) and ophthalmic drugs, including one NMPA-approved product, one NDA under review, and a Phase 3 anti-VEGF candidate.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Supplier concentration
• Reliance on platforms, partners or licences
• Outsourced production (OEM / contract manufacturing)
• Capacity and utilisation
• Losses and path to profitability
• Cash burn and runway
• Preferred shares and fair-value liabilities
• Adverse change after the track record
• Chapter 18A biotech
• Sanctioned countries and export controls